Effects of Bortezomib on Apoptosis and Caspase-3 Expression in Human Umbilical Artery Vascular Smooth Muscle Cells
10.3969/j.issn.1006-5725.2016.19.012
- VernacularTitle:硼替佐米对人脐动脉血管平滑肌细胞凋亡及Caspase-3表达的影响
- Author:
Ying WANG
;
Huili WEI
;
Ruihong SUN
- Publication Type:Journal Article
- Keywords:
Bortezomib;
Vascular Smooth Muscle Cells;
Apoptosis;
Pro-caspase-3;
Cleaved-PARP
- From:
The Journal of Practical Medicine
2016;32(19):3155-3159
- CountryChina
- Language:Chinese
-
Abstract:
Objectives To study the effect of ubiquitin proteasome inhibitor bortezomib on apoptosis and Caspase-3 expression in human umbilical arterial vascular smooth muscle cells. Methods Human umbilical artery vascular smooth muscle cells were cultured in vitro. Different doses of bortezomib (0, 4, 10, 40nmol/L) were used to treat cell. Cell proliferation activity were detected by using CCK8 method. Western Blot assay was used to measure the expression of Pro-caspase-3 and Cleaved-PARP protein. Morphology of cells in different groups are observed by confocal microscopy and apoptosis rate were detected by flow cytometry analysis. Results Bortezomib inhibits proliferation activity of vascular smooth muscle cells. With increasing of drug concentration and treating time, cell viability are reduced (P < 0.01). Cells treated with different concentrations bortezomib for 48 h showed increased apoptosis rate (P < 0.01), decreased pro-caspase-3 protein expression and increased cleaved-PARP protein expression (P < 0.01). Laser confocal microscope found that with the increase of drug concentration, the number of apoptotic cells showed an upward trend under per high-power vision. Conclusion The ubiquitin proteasome inhibitor bortezomib may decrease the expression of pro-caspase-3 and increase Cleaved-PARP expression in human umbilical artery vascular smooth muscle cells. Additionally , it could induce apoptosis in a dose-dependent manner.
